MERIDIAN BIOSCIENCE INC (VIVO) Stock Price, Forecast & Analysis
USA - NASDAQ:VIVO - US5895841014 - Common Stock
VIVO Key Statistics, Chart & Performance
The current stock price of VIVO is 33.97 USD. In the past month the price increased by 2.26%. In the past year, price increased by 41.66%.
VIVO Latest News, Press Relases and Analysis
VIVO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 24.47 | 36.92B | ||
| COO | COOPER COS INC/THE | 17.39 | 13.90B | ||
| SOLV | SOLVENTUM CORP | 11.36 | 11.97B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.26 | 9.99B | ||
| BLCO | BAUSCH + LOMB CORP | 34.74 | 5.29B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.53 | 5.18B | ||
| LNTH | LANTHEUS HOLDINGS INC | 9.03 | 3.92B | ||
| ICUI | ICU MEDICAL INC | 15.97 | 2.97B | ||
| XRAY | DENTSPLY SIRONA INC | 7.37 | 2.52B | ||
| HAE | HAEMONETICS CORP/MASS | 10.75 | 2.41B | ||
| ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.39B | ||
| UFPT | UFP TECHNOLOGIES INC | 22.32 | 1.49B |
Related stock screener links
About VIVO
Company Profile
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. The company is headquartered in Cincinnati, Ohio and currently employs 770 full-time employees. The firm is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized polymerase chain reaction (PCR) master mixes, and bioresearch reagents used by other diagnostic test manufacturers and researchers in immunological and molecular tests for human, animal, plant and environmental applications. The firm's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi'in, Israel. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany.
Company Info
MERIDIAN BIOSCIENCE INC
3471 River Hills Dr
Cincinnati OHIO 45244 US
CEO: Jack Kenny
Employees: 770
Phone: 15132713700.0
MERIDIAN BIOSCIENCE INC / VIVO FAQ
Can you describe the business of MERIDIAN BIOSCIENCE INC?
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. The company is headquartered in Cincinnati, Ohio and currently employs 770 full-time employees. The firm is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized polymerase chain reaction (PCR) master mixes, and bioresearch reagents used by other diagnostic test manufacturers and researchers in immunological and molecular tests for human, animal, plant and environmental applications. The firm's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi'in, Israel. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany.
What is the current price of VIVO stock?
The current stock price of VIVO is 33.97 USD.
What is the dividend status of MERIDIAN BIOSCIENCE INC?
VIVO does not pay a dividend.
What is the ChartMill rating of MERIDIAN BIOSCIENCE INC stock?
VIVO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the Price/Earnings (PE) ratio of MERIDIAN BIOSCIENCE INC (VIVO)?
The PE ratio for MERIDIAN BIOSCIENCE INC (VIVO) is 24.62. This is based on the reported non-GAAP earnings per share of 1.38 and the current share price of 33.97 USD.
What is MERIDIAN BIOSCIENCE INC worth?
MERIDIAN BIOSCIENCE INC (VIVO) has a market capitalization of 1.49B USD. This makes VIVO a Small Cap stock.
When does MERIDIAN BIOSCIENCE INC (VIVO) report earnings?
MERIDIAN BIOSCIENCE INC (VIVO) will report earnings on 2023-05-04, after the market close.
VIVO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to VIVO. When comparing the yearly performance of all stocks, VIVO is one of the better performing stocks in the market, outperforming 93.15% of all stocks.
VIVO Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to VIVO. VIVO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
VIVO Financial Highlights
Over the last trailing twelve months VIVO reported a non-GAAP Earnings per Share(EPS) of 1.38. The EPS decreased by -17.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.75% | ||
| ROA | 9.17% | ||
| ROE | 11.54% | ||
| Debt/Equity | 0.07 |
VIVO Forecast & Estimates
6 analysts have analysed VIVO and the average price target is 34.68 USD. This implies a price increase of 2.09% is expected in the next year compared to the current price of 33.97.
For the next year, analysts expect an EPS growth of -39.02% and a revenue growth -13.66% for VIVO